STOCK TITAN

March 2023 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 22 of 23 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of March 2023 Every stock ranked by its March 2023 gain, with or without news

100

Ranked gains

+298.67%

Largest, USX

86.9%

Above baseline, day +5

18.5%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in March 2023

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 USX +298.67% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Knight-Swift Transportation Agrees to Acquire U.S. Xpress Enterprises for $6.15 Per Share

09:00 ET premarket

2 PRVB +259.70% against the close of 03/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

07:00 ET premarket

3 RETA +198.91% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia

17:25 ET after hours

4 UNCY +153.06% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb

07:00 ET premarket

5 LOCL More than one ranked move this month 2+ ranked moves +110.65% against the close of 03/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Local Bounti Amends Credit Agreement to Provide Additional Flexibility and Provides Select Preliminary and Unaudited Fiscal 2022 Performance

08:31 ET premarket

6 GBNH +106.00% against the close of 03/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Greenbrook TMS Announces US$8.25 Million Equity and Debt Financings

09:00 ET premarket

7 BMEA +99.03% against the close of 03/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Biomea Fusion Announces Positive Data from Initial Cohorts of Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes; 100 mg Cohort 3 Demonstrated an 89% Response Rate and 1% Median Reduction in HbA1c at Day 28

08:00 ET premarket

8 AMAM +95.02% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ambrx to Commence Trading on Nasdaq

09:00 ET premarket

9 BLPH +94.10% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Bellerophon Therapeutics Announces $5 Million Registered Direct Offering

08:30 ET premarket

10 ENZ +89.08% against the close of 03/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

16:30 ET after hours

11 WW +79.07% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition WeightWatchers to Acquire Sequence, a Digital Health Platform for Clinical Weight Management

16:05 ET after hours

12 SCYX +76.05% against the close of 03/29/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

07:05 ET premarket

13 QNCX +71.10% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Echo Lake Capital Offers to Acquire Quince Therapeutics, Inc.

08:00 ET premarket

14 VKTX +69.30% against the close of 03/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735

06:33 ET premarket

15 UHG +64.04% against the close of 03/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell DiamondHead Holdings Corp. and Great Southern Homes Announce Closing of Business Combination to Form United Homes Group, Inc.

16:30 ET after hours

16 OSCR +56.27% against the close of 03/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Oscar Health Announces Appointment of Healthcare Veteran Mark Bertolini to CEO; Co-Founder and CEO Mario Schlosser Transitions to President of Technology

07:00 ET premarket

17 HSTO +54.24% against the close of 03/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use

16:05 ET after hours

18 FCNCA +53.74% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement First Citizens Bank Enters into Whole Bank Purchase of Silicon Valley Bridge Bank, N.A.

01:34 ET premarket

19 YMAB +52.28% against the close of 03/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments

16:01 ET after hours

20 BBIO +51.98% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BridgeBio Announces Positive Phase 2 Cohort 5 Results of Infigratinib in Achondroplasia Demonstrating Mean Increase in Annualized Height Velocity of 3.03 cm/year with No Treatment-related Adverse Events

07:00 ET premarket

21 PTGX +51.91% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Protagonist Therapeutics Announces Positive Topline Results for Phase 2b FRONTIER 1 Clinical Trial of Oral IL-23 Receptor Antagonist JNJ-2113 (PN-235) in Psoriasis

08:00 ET premarket

22 OCX +51.50% against the close of 03/15/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results

16:01 ET after hours

23 TDUP release reads negative +51.23% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 51.23% thredUP Announces Fourth Quarter and Full Year 2022 Results

16:05 ET after hours

24 ARLO +50.14% against the close of 03/07/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arlo Reports Fourth Quarter and Full Year 2022 Results

16:05 ET after hours

25 LOCL More than one ranked move this month 2+ ranked moves +46.86% against the close of 03/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session Local Bounti Secures up to $145 Million of Additional Financing to Support Growth

07:16 ET premarket

26 BRDS +42.19% against the close of 03/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement As Spring Arrives, Bird Announces Expanded Global Operations

08:00 ET premarket

27 WGS +41.30% against the close of 03/17/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”

08:45 ET premarket

28 GRRR Also on the opposite board this month on both boards +41.15% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Gorilla Technology Group Partners with Hailo and Lanner Electronics to Build the Next-generation Edge AI Appliance

07:00 ET premarket

29 GMVD Also on the opposite board this month on both boards +40.84% against the close of 03/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership G MEDICAL INNOVATIONS AND ADVENTHEALTH IN JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS FOR ADVENTHEALTH PATIENTS IN CENTRAL FLORIDA

08:00 ET premarket

30 JNCE More than one ranked move this month 2+ ranked moves +40.57% against the close of 03/14/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

21:00 ET after hours

31 HLLY +39.90% against the close of 03/08/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Holley Reports Fourth Quarter and Full Year 2022 Results

07:30 ET premarket

32 PCT +39.41% against the close of 03/15/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings PureCycle Technologies Provides Fourth Quarter 2022 Update

18:23 ET after hours

33 AMPX +39.09% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement The All-New Amprius 500 Wh/kg Battery Platform is Here

08:30 ET premarket

34 DSEY +37.48% against the close of 03/07/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Diversey to be Acquired by Solenis for $4.6 Billion

06:59 ET premarket

35 SOPH +37.47% against the close of 03/13/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

09:00 ET premarket

36 ALIM +36.91% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility

08:00 ET premarket

37 DM +36.00% against the close of 03/01/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Desktop Metal Announces Fourth Quarter and Full Year 2022 Financial Results and Initiates 2023 Guidance

16:02 ET after hours

38 CDMO +35.96% against the close of 03/13/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

16:05 ET after hours

39 NLTX +35.80% against the close of 03/08/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

17:00 ET after hours

40 PLSE +35.48% against the close of 03/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results

16:05 ET after hours

41 GME release reads negative +35.24% against the close of 03/21/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 35.24% GameStop Reports Fourth Quarter and Fiscal Year 2022 Results

16:05 ET after hours

42 TCRR +33.88% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors

06:00 ET premarket

43 HRTG +33.82% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Heritage Reports Fourth Quarter 2022 Results

16:07 ET after hours

44 AI +33.65% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings C3 AI Announces Fiscal Third Quarter 2023 Financial Results

16:09 ET after hours

45 MCB +33.64% against the close of 03/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Metropolitan Commercial Bank Issues Updated Financial Information

16:41 ET after hours

46 DMS Also on the opposite board this month on both boards +33.42% against the close of 03/29/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution DMS Announces Private Placement of Convertible Preferred Stock

20:01 ET after hours

47 EVTV +33.33% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Envirotech Vehicles Announces Eligibility for Inflation Reduction Act's Commercial Clean Vehicle Credit

06:15 ET premarket

48 CALT +33.23% against the close of 03/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy

23:06 ET after hours

49 UIHC release reads negative +32.99% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 32.99% United Insurance Holdings Corp. Reports Financial Results for Its Fourth Quarter and Year Ended December 31, 2022

16:15 ET after hours

50 PHAR +32.74% against the close of 03/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

14:30 ET intraday

51 SQZ +32.65% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings SQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio Updates

16:45 ET after hours

52 ARDX +32.18% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

16:02 ET after hours

53 NYCB +31.65% against the close of 03/17/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition NEW YORK COMMUNITY BANCORP, INC. THROUGH ITS BANK SUBSIDIARY, FLAGSTAR BANK, N.A., ACQUIRES CERTAIN ASSETS AND ASSUMES CERTAIN LIABILITIES OF SIGNATURE BRIDGE BANK FROM THE FDIC

00:17 ET premarket

54 NRDY +31.08% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Nerdy Announces Fourth Quarter 2022 Financial Results

16:01 ET after hours

55 ARCT +30.13% against the close of 03/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress

16:01 ET after hours

56 CDTX Also on the opposite board this month on both boards +29.80% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cidara Therapeutics Announces Promising Interim Phase 2a Data Assessing the Safety and Efficacy of a Single Dose of CD388 in an Influenza Challenge Model

07:00 ET premarket

57 SEER +29.45% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

16:05 ET after hours

58 BMTX +29.21% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership BM Technologies Secures New Bank Partner and Extends Key Partnerships; New Variable Pricing Structure Benefits Revenues

16:30 ET after hours

59 GBIO +28.87% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

07:00 ET premarket

60 BGS +28.49% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings B&G Foods Reports Financial Results for Fourth Quarter and Full Year 2022

16:05 ET after hours

61 SY +27.87% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results

05:00 ET premarket

62 NOGN Also on the opposite board this month on both boards +27.15% against the close of 03/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Nogin Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

16:22 ET after hours

63 RRGB +27.14% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Fourth Quarter and Fiscal Year Ended December 25, 2022

16:05 ET after hours

64 CVM +26.50% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results CEL-SCI to Present New Phase 3 Data at European Congress on Head & Neck Oncology

09:00 ET premarket

65 BLBX +26.47% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Blackboxstocks Retires 687,761 Common Shares Held in Treasury

08:00 ET premarket

66 ONON +26.38% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings On Announces Fourth Quarter and Full Year Results, and The Filing of Its Annual Report on Form 20-F for 2022

06:00 ET premarket

67 MARA release reads negative +25.70% against the close of 03/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Release reads negative, stock rose 25.70% Marathon Digital Holdings Responds to Closure of Signature Bank, New York, NY

09:36 ET intraday

68 ANGH +25.68% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Anghami Reports 35.6% Revenue Growth in Preliminary Unaudited 2022 Results, with Focus on Continued Efficiency and Profitability for 2023

11:39 ET intraday

69 REKR +25.35% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Rekor Systems Awarded Contract by Florida Department of Transportation and the City of Tallahassee for Non-Intrusive Roadway Data Collection

07:30 ET premarket

70 ETNB More than one ranked move this month 2+ ranked moves +25.16% against the close of 03/21/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results 89bio’s Phase 2b ENLIVEN Trial of Pegozafermin in Nonalcoholic Steatohepatitis (NASH) Achieved High Statistical Significance on Both Primary Histology Endpoints with Weekly (QW) and Every-Two-Week (Q2W) Dosing at 24 Weeks

07:00 ET premarket

71 BXRX +25.16% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000

08:00 ET premarket

72 SCPH +25.14% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

16:05 ET after hours

73 GRPN +24.93% against the close of 03/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Groupon Announces CEO Transition

07:45 ET premarket

74 TLSA More than one ranked move this month 2+ ranked moves +24.42% against the close of 03/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Tiziana Life Sciences to Proceed with Phase 2 Clinical Trial in Patients with Non-Active Secondary Progressive Multiple Sclerosis (SPMS)

07:00 ET premarket

75 EYPT +24.12% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results EyePoint Pharmaceuticals Completes Enrollment in Oversubscribed Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for Maintenance Treatment of Wet AMD

07:00 ET premarket

76 DCTH +23.97% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023

08:10 ET premarket

77 GAIA +23.95% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gaia Reports Fourth Quarter and Full Year 2022 Results

16:05 ET after hours

78 ETNB More than one ranked move this month 2+ ranked moves +23.83% against the close of 03/22/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

16:16 ET after hours

79 SMIH also YS +23.81% against the close of 03/14/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION

16:38 ET after hours

80 MESO +23.76% against the close of 03/07/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory FDA Accepts Mesoblast’s Resubmission of the Biologic License Application for Remestemcel-L In Children with Steroid-Refractory Acute Graft Versus Host Disease as a Complete Response and Sets Goal Date of August 2, 2023

19:03 ET after hours

81 VERX +23.72% against the close of 03/07/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Vertex Announces Fourth Quarter and Full Year 2022 Financial Results

07:05 ET premarket

82 HYPR +23.68% against the close of 03/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

08:55 ET premarket

83 KOD +23.27% against the close of 03/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Kodiak Sciences Announces Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

16:08 ET after hours

84 IMPP +23.12% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Imperial Petroleum Announces Management Estimate of Net Asset Value Per Share- $1.39

09:20 ET premarket

85 LXRX +22.94% against the close of 03/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update

16:00 ET after hours

86 TLSA More than one ranked move this month 2+ ranked moves +22.42% against the close of 03/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tiziana Life Sciences Highlighted in Forbes Article

07:00 ET premarket

87 OSPN +22.41% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings OneSpan Reports Fourth Quarter and Full Year 2022 Financial Results

16:01 ET after hours

88 DUOL +22.24% against the close of 02/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Duolingo Reports 62% DAU Growth; Record Bookings and Revenue in Fourth Quarter and Full Year 2022

16:01 ET after hours

89 EVGO +22.09% against the close of 03/29/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings EVgo Inc. Reports Fourth Quarter and Full Year 2022 Results

07:00 ET premarket

90 PLPC +21.87% against the close of 03/01/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings PREFORMED LINE PRODUCTS ANNOUNCES RECORD FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

16:30 ET after hours

91 CURV +21.85% against the close of 03/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Torrid Reports Fourth Quarter and Fiscal 2022 Results

16:05 ET after hours

92 SE +21.84% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Sea Limited Reports Fourth Quarter and Full Year 2022 Results

06:30 ET premarket

93 RIGL +21.77% against the close of 03/07/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

16:01 ET after hours

94 COOK +21.59% against the close of 03/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Traeger Announces Fourth Quarter and Full Year 2022 Results

16:05 ET after hours

95 ENVX +21.44% against the close of 03/28/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Enovix Announces Manufacturing Partner and Location for Fab-2 in Malaysia

07:30 ET premarket

96 ALLK +21.30% against the close of 03/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

16:02 ET after hours

97 ATHX +21.19% against the close of 03/21/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Athersys Announces Successful Type B Meeting with the FDA

08:30 ET premarket

98 JNCE More than one ranked move this month 2+ ranked moves +21.19% against the close of 03/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights

09:00 ET premarket

99 SRZN Also on the opposite board this month on both boards +21.18% against the close of 03/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Surrozen To Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 22, 2023

16:30 ET after hours

100 TAYD +21.16% against the close of 03/29/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS

08:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 914 smaller events this month are held out of this month's eligible pool; switch to include them. 336 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.

1 event was left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

2 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In March 2023, the median gainer had given back 18.5% of its move five sessions later; the largest catalyst group was Earnings, 42 of the 100 events, at a median of +29.0%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Earnings 42 42.0% +29.0% +23.9% 88.1% of 42
Other Announcement 20 20.0% +35.7% +37.5% 85.0% of 20
Clinical Trial Results 11 11.0% +29.8% +38.2% 90.9% of 11
M&A / Acquisition 7 7.0% Fewer than 10 events in this group, so no figures are shown.
Contract / Partnership 6 6.0% Fewer than 10 events in this group, so no figures are shown.

5 other catalyst types, 14 events: FDA & Regulatory, Offering / Dilution, Reverse Merger / Shell, Leadership Change, Crypto & Treasury.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 98.0% of 100 0.4% given back, of 100
Day +5 86.9% of 99 18.5% given back, of 99
Month end 85.1% of 94 7.5% further above baseline, of 94
Month end falls before day +5 for 22 of these 94 events, so this row is not a later horizon than the one above it. 94 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside March 2023

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
LOCL 2Earnings +110.65%
JNCE 2M&A / Acquisition +40.57%
ETNB 2Clinical Trial Results, Offering / Dilution +25.16%
TLSA 2Clinical Trial Results, Other Announcement +24.42%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
HILS 2023-02, 2023-01, 2022-12 +78.84%
AMAMthis month too 2023-02, 2022-12 +1007.59%
MOB 2023-02, 2023-01 +41.29%
GNS 2023-02, 2023-01 +290.29%
CLXT 2023-02, 2023-01 +90.25%
NGL 2023-02, 2023-01 +21.93%
HARP 2023-02, 2022-12 +22.61%
HOTH 2023-02, 2022-12 +143.64%
COSM 2023-01, 2022-12 +72.49%
POL 2023-01, 2022-12 +55.70%
GRRRthis month too 2023-01, 2022-12 +47.25%
LASE 2023-01, 2022-12 +38.34%
BXRXthis month too 2023-01, 2022-12 +32.38%
FFIE 2023-01, 2022-12 +55.53%
NAAS 2023-01, 2022-12 +30.10%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market51.0%
  • Intraday3.0%
  • After hours46.0%

Volume against normal

  • Under 5x16 events, 16.0%
  • 5x to 20x43 events, 43.0%
  • Over 20x41 events, 41.0%

Industry

  • Pharmaceutical Preparations18 events, 18.0%
  • Biological Products, (no Diagnostic Substances)4 events, 4.0%
  • Services-prepackaged Software3 events, 3.0%
  • State Commercial Banks3 events, 3.0%
  • Laboratory Analytical Instruments2 events, 2.0%
  • Miscellaneous Electrical Machinery, Equipment & Supplies2 events, 2.0%

31 other industries, 33 events

Industry not known: 35.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against February 2023

100 events in the comparable window.

February 2023 median +26.1%, selected from the 9,398 events in that month's eligible pool

March 2023 median +32.7%, 6.6 points above February 2023. March 2023's median is taken over the 100 ranked rows, selected from the 9,373 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.